A novel sporadic Burkitt lymphoma cell line (BLUE-1) with a unique 
t(6;20)(q15;q11.2) rearrangement

Burmeister, Thomas; MacLeod, Roderick A. F.; Reinhardt, Richard; Mansmann, Veit; Loddenkemper, Christoph; Marinets, Olga; Drexler, Hans G.; Thiel, Eckhard; Blau, Igor Wolfgang

doi:10.1016/j.leukres.2006.03.026

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

A novel sporadic Burkitt lymphoma cell line (BLUE-1) with a unique t(6;20)(q15;q11.2) rearrangement

MPS-Authors

/persons/resource/persons50488

Reinhardt, Richard
High Throughput Technologies, Max Planck Institute for Molecular Genetics, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Burmeister, T., MacLeod, R. A. F., Reinhardt, R., Mansmann, V., Loddenkemper, C., Marinets, O., Drexler, H. G., Thiel, E., & Blau, I. W. (2006). A novel sporadic Burkitt lymphoma cell line (BLUE-1) with a unique t(6;20)(q15;q11.2) rearrangement. Leukemia Research: Interdisciplinary International, 30(11), 1417-1423. doi:10.1016/j.leukres.2006.03.026.

引用: https://hdl.handle.net/11858/00-001M-0000-0010-8347-4

要旨

We report the establishment and characterization, including HLA-typing, immunophenotypic and molecular cytogenetic analysis, of a novel EBV-negative cell line (BLUE-1) derived from adult relapsed sporadic Burkitt lymphoma. BLUE-1 carries the pathognomonic t(8;14)(q24;q32) effecting MYC/IgHJ fusion and a novel t(6;20)(q15;q11.2) originally present in the patient, analysis of which may facilitate identification of gene target(s) of recurrent 6q rearrangements in B-cell neoplasia. Our findings are discussed in light of the current understanding of endemic and sporadic Burkitt lymphoma. BLUE-1 grows well in culture and should be a useful lymphoma research tool.